サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494454

アジア太平洋のマイクロキャリア：2030年市場予測-地域別分析-製品、装置、用途、エンドユーザー別

Asia Pacific Microcarriers Market Forecast to 2030 - Regional Analysis - by Product, Equipment, Application, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 96 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.53円
アジア太平洋のマイクロキャリア：2030年市場予測-地域別分析-製品、装置、用途、エンドユーザー別
出版日: 2024年04月05日
発行: The Insight Partners
ページ情報: 英文 96 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋のマイクロキャリア市場は、2022年の3億6,614万米ドルから2030年には9億9,123万米ドルに成長すると予想されています。2022～2030年のCAGRは13.3%を記録すると推定されています。

再生医療導入の急増がアジア太平洋マイクロキャリア市場を後押し

再生医療の採用が増加していることが、マイクロキャリア市場の成長を促進する重要な要因となっています。再生医療は、損傷した組織や臓器の修復、置換、再生に焦点を当てており、様々な病状に対処するための有望なセグメントとなっています。マイクロキャリアは、再生医療の基本である細胞の培養と増殖において極めて重要な役割を果たしています。

再生医療では、移植前に体外で細胞を培養するが、マイクロキャリアは細胞の接着、増殖、分化に適した環境を記載しています。マイクロキャリアは、バイオリアクターにおける細胞増殖の基質として機能し、大量の細胞を効率的に生産することを容易にします。これは、相当数の生存可能で機能的な細胞が必要とされる再生治療にとって特に重要です。

さらに、マイクロキャリアは細胞プロセスのスケーラビリティと費用対効果を高め、再生医療を研究から臨床応用に移す際の重要な課題に対処します。幹細胞治療と組織工学への注目が高まる中、再生医療セグメントの進歩が続くにつれ、マイクロキャリアの需要は拡大し、マイクロキャリア市場の革新と拡大を促進すると予想されます。

アジア太平洋のマイクロキャリア市場概要

アジア太平洋のマイクロキャリア市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋に区分されます。アジア太平洋のいくつかの国は、細胞と遺伝子治療の研究開発に多額の投資を行っています。中国、インド、日本は、この地域のマイクロキャリア市場の成長に大きく貢献している3カ国であり、市場成長の背景には、コスト最適化を重視する企業の増加、臨床プロセスの合理化への取り組みの急増、政府の支援政策、臨床試験件数の増加があります。中華人民共和国政府は、公衆衛生の向上、費用対効果の高い公衆衛生プログラムの提供、健康関連の財政保護措置の適用範囲の拡大、広大な医療提供ネットワークへの投資に注力しています。中国の第13次計画では、2020年のバイオテクノロジー産業のGDPへの寄与が4％を超えると予想されており、これは10～20近い生命科学並みの規模になります。地方政府が管理する100以上のライフサイエンス・パークが中国全土で機能しており、これらのセンターは税制優遇や補助金で企業を誘致しています。米国、省、地方政府は、中国の5ヵ年計画の目標を達成するために、すでに1,000億米ドル以上をバイオサイエンスセグメントに投資したと報告されています。2003年、中国は遺伝子治療を承認した最初の国となり、それ以来、治療効果の高い細胞治療や遺伝子治療の開発が世界的に加速しています。2021年にネイチャー誌に発表された研究によると、中国は世界の細胞治療試験の50％以上を実施しています。同国では現在、血液学、腫瘍学、固形腫瘍を中心に400近くのCAR-T試験が進行中です。2021年には、国家医療製品管理局（NMPA）がFosun KiteのYescartaとJW TherapeuticsのRelma-celを承認し、中国の細胞療法は新たな時代を迎えました。

アジア太平洋マイクロキャリア市場の収益と2030年までの予測（金額）

アジア太平洋マイクロキャリア市場のセグメンテーション

アジア太平洋のマイクロキャリア市場は、製品、装置、用途、エンドユーザー、国に区分されます。

製品別では、アジア太平洋のマイクロキャリア市場はマイクロキャリアビーズと培地・試薬に二分されます。2022年のアジア太平洋マイクロキャリア市場では、マイクロキャリアビーズセグメントが大きなシェアを占めています。

装置では、アジア太平洋マイクロキャリア市場はバイオリアクター、培養容器、その他に区分されます。バイオリアクターセグメントは、2022年にアジア太平洋マイクロキャリア市場で最大のシェアを占めました。

用途別では、アジア太平洋マイクロキャリア市場はバイオ医薬品生産、細胞・遺伝子治療、組織工学・再生医療、その他に区分されます。2022年のアジア太平洋マイクロキャリア市場では、バイオ医薬品生産セグメントが最大のシェアを占めています。さらに、バイオ医薬品生産セグメントは、治療用タンパク質生産とワクチン生産に分類されます。

エンドユーザーに基づいて、アジア太平洋マイクロキャリア市場は製薬・バイオテクノロジー企業、受託研究機関・受託製造機関、学術・研究機関に区分されます。2022年のアジア太平洋マイクロキャリア市場では、製薬・バイオテクノロジー企業が最大シェアを占めています。

国別に見ると、アジア太平洋マイクロキャリア市場は中国、日本、インド、韓国、オーストラリア、その他のアジア太平洋に区分されます。2022年のアジア太平洋マイクロキャリア市場は中国が独占。

Teijin Ltd、Bio-Rad Laboratories Inc、Sartorius AG、Danaher Corp、Corning Inc、Eppendorf SE、旭化成Corp、Polysciences Incは、アジア太平洋マイクロキャリア市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブ概要

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋マイクロキャリア市場-主要産業力学

  • 主要市場促進要因
    • がんと感染症の増加に伴う細胞治療のニーズ
    • 細胞・遺伝子治療製造のアウトソーシング人気の高まり
    • 再生医療導入の急増
  • 市場抑制要因
    • 生物製剤と細胞ベースの治療の高コスト
  • 市場機会
    • マイクロキャリアメーカーによる戦略的取り組みと革新的製品
  • 今後の動向
    • 細胞・遺伝子治療製造サービスの自動化
  • 影響分析

第5章 マイクロキャリア市場：アジア太平洋市場分析

  • マイクロキャリア市場の売上高、2022～2030年

第6章 アジア太平洋マイクロキャリア市場の収益と2030年までの予測：製品別

  • イントロダクション
  • マイクロキャリア市場の製品別売上高シェア（%）、2022年と2030年
  • マイクロキャリアビーズ
  • 培地・試薬

第7章 アジア太平洋マイクロキャリア市場：装置別収益と2030年までの予測

  • イントロダクション
  • マイクロキャリア市場の装置別売上高シェア（%）、2022年と2030年
  • バイオリアクター
  • 培養容器
  • その他

第8章 アジア太平洋マイクロキャリア市場の収益と2030年までの予測：用途別

  • イントロダクション
  • マイクロキャリア市場の用途別売上高シェア（%）、2022年と2030年
  • バイオ医薬品生産
  • 細胞・遺伝子治療
  • 組織工学と再生医療
  • その他

第9章 アジア太平洋マイクロキャリア市場の収益と2030年までの予測：エンドユーザー別

  • イントロダクション
  • アジア太平洋のマイクロキャリア市場：エンドユーザー別シェア、2022年と2030年（%）
  • 製薬・バイオテクノロジー企業
    • 製薬・バイオテクノロジー企業：マイクロキャリア市場～2030年までの収益と予測
  • 受託研究機関・受託製造機関
    • 受託研究機関・受託製造機関：マイクロキャリア市場：2028年までの収益と予測
  • 学術・研究機関
    • 学術・研究機関：マイクロキャリア市場：2028年までの収益と予測

第10章 アジア太平洋のマイクロキャリア市場の収益と2030年までの予測：国別分析

    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他のアジア太平洋

第11章 マイクロキャリア市場-業界情勢

  • イントロダクション
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Asahi Kasei Corp
  • Polysciences Inc

第13章 付録

図表

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. China Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. China Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. China Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. China Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. China: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. Japan Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. Japan Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. Japan Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. Japan Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. Japan: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. India Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. India Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. India Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. India Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. India: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Australia Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 18. Australia Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 19. Australia Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Australia Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 21. Australia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 22. South Korea Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 23. South Korea Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 24. South Korea Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 25. South Korea Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 26. South Korea: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 27. Rest of Asia Pacific Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 28. Rest of Asia Pacific Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 29. Rest of Asia Pacific Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Rest of Asia Pacific Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. Recent Organic Growth Strategies in Microcarriers Market
  • Table 33. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 34. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. Microcarriers Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 10. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Asia Pacific Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Microcarriers Market, 2022 (US$Mn)
  • Figure 25. Asia Pacific: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 26. China: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Australia: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00029978

The Asia Pacific microcarriers market is expected to grow from US$ 366.14 million in 2022 to US$ 991.23 million by 2030. It is estimated to record a CAGR of 13.3% from 2022 to 2030.

Surge in Adoption of Regenerative Medicine Fuels Asia Pacific Microcarriers Market

The rising adoption of regenerative medicine has emerged as a significant driver propelling the growth of the microcarriers market. Regenerative medicine focuses on repairing, replacing, or regenerating damaged tissues and organs, making it a promising field for addressing various medical conditions. Microcarriers play a pivotal role in the cultivation and expansion of cells, a fundamental aspect of regenerative medicine.

In regenerative medicine, cells are cultured outside the body before being transplanted, and microcarriers provide a suitable environment for cell attachment, proliferation, and differentiation. They serve as a substrate for cell growth in bioreactors, facilitating the efficient production of large quantities of cells. This is particularly crucial for regenerative therapies, where a substantial number of viable and functional cells are needed.

Moreover, microcarriers enhance the scalability and cost-effectiveness of cell processes, addressing key challenges in the translation of regenerative medicine from research to clinical applications. As the regenerative medicine field continues to advance, with an increasing focus on stem cell therapies and tissue engineering, the demand for microcarriers is expected to escalate, driving innovation and expansion within the microcarriers market

Asia Pacific Microcarriers Market Overview

The microcarrier market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific countries. Several countries in Asia Pacific invest significantly in cell and gene therapy R&D. China, India, and Japan are the three major contributors to the growth of the microcarriers market in this region, and the market growth can be attributed to the growing emphasis of businesses on cost optimization, burgeoning efforts to streamline clinical processes, supportive government policies, and increasing number of clinical trials. The government of the People's Republic of China is focused on improving public health, providing cost-effective public health programs, expanding the coverage of health-related financial protection measures, and investing in a vast healthcare delivery network. The 13th Chinese plan expected a more than 4% contribution of the biotechnology industry to the GDP in 2020, which would be nearly 10-20 life-science parities. More than 100 life-science parks controlled by local governments are functional across China, and these centers entice enterprises with tax advantages and subsidies. State, provincial, and local governments are reported to have already invested more than US$ 100 billion in the biosciences sector to meet the goals of the five-year plan of China. In 2003, it became the first country to approve a gene therapy, and since then, the development of cell and gene therapies with elevated therapeutic potential has picked pace worldwide. According to a study published in Nature in 2021, China is home to more than 50% of all cell therapy trials across the world. The country currently has nearly 400 ongoing CAR-T trials centered on hematology, and oncology and solid tumors. In 2021, the National Medical Products Administration (NMPA) approved Fosun Kite's Yescarta and JW Therapeutics' Relma-cel, with which cell therapies in China entered a new era.

Asia Pacific Microcarriers Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Microcarriers Market Segmentation

The Asia Pacific microcarriers market is segmented into product, equipment, application, end user, and country.

Based on product, the Asia Pacific microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the Asia Pacific microcarriers market in 2022.

In terms of equipment, the Asia Pacific microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the Asia Pacific microcarriers market in 2022.

Based on application, the Asia Pacific microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the Asia Pacific microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the Asia Pacific microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the Asia Pacific microcarriers market in 2022.

Based on country, the Asia Pacific microcarriers market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific microcarriers market in 2022.

Teijin Ltd, Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the Asia Pacific microcarriers market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Microcarriers Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
    • 4.1.3 Surge in Adoption of Regenerative Medicine
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Biologics and Cell-based Therapies
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 4.4 Future Trends
    • 4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 4.5 Impact Analysis

5. Microcarriers Market - Asia Pacific Market Analysis

  • 5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Microcarrier Beads
    • 6.3.1 Overview
    • 6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Media and Reagents
    • 6.4.1 Overview
    • 6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 7.3 Bioreactors
    • 7.3.1 Overview
    • 7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Culture Vessels
    • 7.4.1 Overview
    • 7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Biopharmaceutical Production
    • 8.3.1 Overview
    • 8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cell and Gene Therapy
    • 8.4.1 Overview
    • 8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Tissue Engineering and Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 9.1 Overview
  • 9.2 Asia Pacific Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Microcarriers Market Revenue and Forecasts to 2030 - Country Analysis

  • 10.1 Asia Pacific Microcarriers Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific: Microcarriers Market, by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
        • 10.1.2.1.3 China: Microcarriers Market, by Product
        • 10.1.2.1.4 China: Microcarriers Market, by Equipment
        • 10.1.2.1.5 China: Microcarriers Market, by Application
        • 10.1.2.1.5.1 China: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.1.6 China: Microcarriers Market, by End User
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Japan: Microcarriers Market, by Product
        • 10.1.2.2.4 Japan: Microcarriers Market, by Equipment
        • 10.1.2.2.5 Japan: Microcarriers Market, by Application
        • 10.1.2.2.5.1 Japan: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.2.6 Japan: Microcarriers Market, by End User
      • 10.1.2.3 India
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 India: Microcarriers Market, by Product
        • 10.1.2.3.4 India: Microcarriers Market, by Equipment
        • 10.1.2.3.5 India: Microcarriers Market, by Application
        • 10.1.2.3.5.1 India: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.3.6 India: Microcarriers Market, by End User
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
        • 10.1.2.4.3 Australia: Microcarriers Market, by Product
        • 10.1.2.4.4 Australia: Microcarriers Market, by Equipment
        • 10.1.2.4.5 Australia: Microcarriers Market, by Application
        • 10.1.2.4.5.1 Australia: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.4.6 Australia: Microcarriers Market, by End User
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 South Korea: Microcarriers Market, by Product
        • 10.1.2.5.4 South Korea: Microcarriers Market, by Equipment
        • 10.1.2.5.5 South Korea: Microcarriers Market, by Application
        • 10.1.2.5.5.1 South Korea: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.5.6 South Korea: Microcarriers Market, by End User
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Rest of Asia Pacific: Microcarriers Market, by Product
        • 10.1.2.6.4 Rest of Asia Pacific: Microcarriers Market, by Equipment
        • 10.1.2.6.5 Rest of Asia Pacific: Microcarriers Market, by Application
        • 10.1.2.6.5.1 Rest of Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.6.6 Rest of Asia Pacific: Microcarriers Market, by End User

11. Microcarriers Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Teijin Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Bio-Rad Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sartorius AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Danaher Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Corning Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Eppendorf SE
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Asahi Kasei Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Polysciences Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms